Evidence map›Paper›PMID 41413371›Full record

ArticleCalcified tissue international2025

Bone Material Properties in Male Idiopathic Osteoporosis.

Roland Kocijan, Martina Behanova, Stéphane Blouin, Michaela Layr, Jochen Zwerina, Judith Haschka, Markus A Hartmann

Abstract read
PubMed Publisher
In one paragraph

Article in Calcified tissue international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Roland KocijanLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Heinrich-Collin-Strasse 30, 1140, Vienna, Austria.
Martina BehanovaLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Heinrich-Collin-Strasse 30, 1140, Vienna, Austria.ORCID http://orcid.org/0000-0002-5449-0223
Stéphane BlouinLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Heinrich-Collin-Strasse 30, 1140, Vienna, Austria.
Michaela LayrLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Heinrich-Collin-Strasse 30, 1140, Vienna, Austria.
Jochen ZwerinaLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Heinrich-Collin-Strasse 30, 1140, Vienna, Austria.
Judith HaschkaLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Heinrich-Collin-Strasse 30, 1140, Vienna, Austria.
Markus A HartmannLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Heinrich-Collin-Strasse 30, 1140, Vienna, Austria. markus.hartmann@lbg.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMale idiopathic osteoporosis (MIO), defined as primary osteoporosis with unclear etiology in men, is characterized by low bone mass and increased fracture risk. The underlying pathophysiology remains poorly understood, particularly regarding bone microstructure, turnover, and mineralization. PURPOSE: To characterize bone material properties in men with idiopathic osteoporosis using histomorphometry, bone mineralization analysis, and osteocyte lacunae morphology.

methodsTransiliac bone biopsies from 20 men with idiopathic osteoporosis (mean age 46.5 ± 12.1 years) were analyzed after exclusion of secondary causes. Undecalcified PMMA-embedded samples were assessed for static and dynamic histomorphometric parameters. Dynamic bone formation was evaluated using tetracycline double labeling. Quantitative backscattered electron imaging determined bone mineralization density distribution in cortical and trabecular compartments and osteocyte lacunae section characteristics.

resultsCompared with age-matched reference data, patients exhibited significantly reduced trabecular bone volume fraction (p = 0.007), thickness (p = 0.003), and number (p = 0.03), alongside decreased osteoid thickness (p < 0.001) and osteoblast surface (p = 0.002). Dynamic analysis revealed lower adjusted apposition rate (p = 0.003) and prolonged mineralization lag time (p = 0.007), indicating low bone turnover. Trabecular bone mineralization was reduced, with lower CaMean (p = 0.001), CaPeak (p < 0.001), and CaHigh (p = 0.007), and higher CaLow (p = 0.02). Cortical mineralization remained normal, although cortical width was decreased (p = 0.044). Osteocyte lacunar aspect ratio was significantly reduced in cortical and trabecular bone (both p < 0.001), while lacunar density and area were unchanged.

conclusionMen with idiopathic osteoporosis present a distinct skeletal phenotype characterized by compromised trabecular microarchitecture, suppressed bone formation, and selective trabecular hypomineralization, despite preserved cortical mineralization. These findings suggest that MIO represents a low-turnover bone disorder with impaired mineralization kinetics.

Indexed as

Bone and BonesBone DensityOsteoporosisAdultBone RemodelingCalcification, PhysiologicHumansMaleMiddle AgedOsteocytesBone histomorphometryBone mineralization density distribution (BMDD)Low bone turnoverMale idiopathic osteoporosisOsteocyte lacunaeQuantitative backscattered electron imaging (qBEI)Trabecular bone microarchitectureTransiliac bone biopsy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.